Oncolytics Biotech
ONCY
#9651
Rank
NZ$0.17 B
Marketcap
NZ$1.43
Share price
-3.60%
Change (1 day)
-30.40%
Change (1 year)

Oncolytics Biotech (ONCY) - Cash on Hand

Cash on Hand as of March 2026 : NZ$9.47 Million

According to Oncolytics Biotech 's latest financial reports the company has NZ$9.47 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Oncolytics Biotech - Cash on Hand chart (from 2000 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$8.98 M-54.28%
2024-12-31NZ$19.64 M-52.79%
2023-12-31NZ$41.61 M11.58%
2022-12-31NZ$37.29 M-21.28%
2021-12-31NZ$47.37 M39.63%
2020-12-31NZ$33.93 M110.99%
2019-12-31NZ$16.08 M7.25%
2018-12-31NZ$14.99 M13.15%
2017-12-31NZ$13.25 M-12.63%
2016-12-31NZ$15.16 M-44.75%
2015-12-31NZ$27.45 M54.3%
2014-12-31NZ$17.79 M-42.81%
2013-12-31NZ$31.11 M19.58%
2012-12-31NZ$26.01 M-40.52%
2011-12-31NZ$43.74 M-21.34%
2010-12-31NZ$55.6 M23.91%
2009-12-31NZ$44.87 M138.71%
2008-12-31NZ$18.79 M-43.44%
2007-12-31NZ$33.23 M-1.16%
2006-12-31NZ$33.62 M-33.94%
2005-12-31NZ$50.9 M28.72%
2004-12-31NZ$39.54 M60.62%
2003-12-31NZ$24.61 M143.82%
2002-12-31NZ$10.09 M-55.41%
2001-12-31NZ$22.64 M-14.59%
2000-12-31NZ$26.51 M341.15%
1999-12-31NZ$6.01 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eli Lilly
LLY
NZ$9.10 B 96,058.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$18.08 B 190,797.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
NZ$1.68 B 17,675.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
NZ$47.94 M 406.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$6.45 B 68,004.86%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
NZ$0.13 B 1,309.03%๐Ÿ‡บ๐Ÿ‡ธ USA